secwatch / observer
8-K filed February 20, 2024, 6:59 PM ET ticker MD CIK 0000893949
earnings confidence high sentiment negative materiality 0.75

Pediatrix Q4 GAAP loss $1.50/share; adj EPS $0.32; 2024 EBITDA guidance $200-220M

Pediatrix Medical Group, Inc.

2023-FY EPS reported $0.73 revenue$1,994,640,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Pediatrix Medical Group, Inc. reported the year ended December 31, 2023 results: revenue $1.99 billion.

Period
the year ended December 31, 2023
Revenue
$1.99 billion
Result
reported results
Exact text from the filing
For the year ended December 31, 2023, Pediatrix generated revenue from continuing operations of $1.99 billion, compared to $1.97 billion for the prior year.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Pediatrix Medical Group, Inc. reported the three months ended December 31, 2023 results: revenue $496 million, net income Loss from continuing operations of $124 million, EPS loss from continuing operations of $1.50 per diluted share.

Period
the three months ended December 31, 2023
Revenue
$496 million
Net income
Loss from continuing operations of $124 million
EPS
loss from continuing operations of $1.50 per diluted share
Result
reported results
Exact text from the filing
For the 2023 fourth quarter, Pediatrix reported the following results from continuing operations: • Net revenue of $496 million; • Loss from continuing operations of $124 million; and • Adjusted EBITDA of $51 million.
View on SEC.gov

Browse all earnings releases →

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-24-016790
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.